Wellsense, a US-based developer of continuous bedside monitoring MAP system, has appointed Eitan Machover as the company's new chief executive officer (CEO) and a director.
Prior to joining the company, Machover served at General Electric and held various strategic business with GE Healthcare as general manager of integration and business development as well as served in the capacity of the national executive for General Electric in Israel.
He also worked as a founding and general partner at MediTech Advisors, a medical device venture capital firm with two funds with over $70m under management.
Wellsense founder and board chairman Ran Poliakine said, "Wellsense's MAP System is uniquely positioned to help address the prevention of pressure ulcers, commonly known as bed sores, which are a huge cost burden to the healthcare system."
Machover said healthcare providers can reduce costs and patient suffering by using the MAP system that provides bedside visual feedback of pressure mapping.
"Pressure ulcers are a serious problem across the continuum of care and we believe that the MAP? System has widespread applications, from operating rooms during extremely long surgeries, to acute care settings like ICUs and spinal cord injury units, to long term care settings like burn centers and rehab facilities, and eventually to the home setting. Our innovative technology has the potential to establish a new standard of care for patient safety," Machover added.